Areas of Interest

LIVFRESH Dental Gel toothpaste
is already approved in EU

for Prevention & Treatment of Periodontitis, Gingivitis, & Caries

FEATURED IN

nbc logo
abc logo
fox logo
good housekeeping logo<br />
GQ logo
WSJ logo

PLAQUE CONTROL

We have the first breakthrough in the dental industry since the introduction of fluoride in 1914.

LIVFRESH Dental Gel toothpaste is clinically proven to remove plaque 250% BETTER than a market leader.

All ingredients are edible and contain ZERO abrasives, antimicrobials, parabens, gluten, sugar, triclosan, & SLS.

LIVFRESH is commercially available in USA.

Dental get Tubes sold

# of Customers

5-Star Reviews

graph

REFERENCE: PMID 26052472

PERIODONTITIS

Periodontitis is a serious gum disease whose progression can be delayed by in office procedures like scaling and root planing (SRP), 3 monthly professional cleaning, etc.  In contrast, gingivitis is characterized by gum inflammation/bleeding and is generally considered reversible. Periodontitis leads to significant discomfort/pain, loss of teeth, and a substantial decrease in the quality of life. Periodontitis has also been linked to dementia, Alzheimer’s, cardiac disease, and other systemic diseases.

Prevalance

64M

PATIENTS IN THE US

tooth-image-block

Increasing prevalence due to the aging population and the lack of availability of effective home care. According to the CDC, at least 47% of all US adults above 30 years, suffer from periodontitis.

Current standard of care are in-office treatments to slow down progression of periodontitis which can be painful, time-intensive, and expensive. Baseline treatments include scaling and root planing, and professional cleanings every 3 months. Surgery is suggested for advanced cases.

LIVFRESH Dental Gel toothpaste
Possible first affordable at-home treatment

checkmark

Double-Blind Study Shows Reduction of Pocket Depths

Pocket Depth > 4 mm are a marker for periodontitis. In the double-blind study, the LIVFRESH group showed  significant reductions in diseased pocket depths, gum inflammation, gum bleeding and dental plaque.

checkmark

Ready to launch FDA Phase 2 study

Approval would make LIVFRESH the first affordable, at-home treatment for severe gum disease in USA

80% of the Diseased Pocket Depths
Were Reduced in the LIVFRESH group

perio-chart

REFERENCE: PMID 33331040

LIVFRESH  is planning to launch an anti-gingivitis toothpaste in 2025

Clinical Parameters Associated with Gingivitis

Superior Efficacy versus Leading Brand Anti-Gingivitis Toothpastes

3-Month Randomized Controlled Trial (RCT) in 150 Patients with Gingivitis – 30 Patients per Study Arm

Plaque Control, Gum Inflammation, Bleeding Chart
Plaque Reduction
Gingival Reduction
Bleeding On Probing Reduction

REFERENCE: PMID 37016272